Title:
起立性低血圧の予防又は改善用剤及びそれを含む組成物
Document Type and Number:
Japanese Patent JP7063514
Kind Code:
B2
Abstract:
The present invention aims to provide an agent for preventing or ameliorating orthostatic hypotension, which agent is highly safe and effective, causes less side effects, and can be continuously used for a long time.One embodiment of the present invention is an agent for preventing or ameliorating orthostatic hypotension comprising, as an active ingredient, a lactic acid bacterium, Lactobacillus delbrueckii subspecies lactis or a lactic acid bacterium-derived ingredient therefrom.
More Like This:
Inventors:
Katsutaro Nagata
Application Number:
JP2021562609A
Publication Date:
May 09, 2022
Filing Date:
November 26, 2020
Export Citation:
Assignee:
Life Quality Institute Co., Ltd.
International Classes:
A61K35/747; A23K10/16; A23L33/135; A61K31/702; A61K31/716; A61K31/721; A61K31/729; A61K31/731; A61K31/732; A61K31/733; A61K31/734; A61K31/736; A61P9/02; A61P43/00
Foreign References:
| WO2008120713A1 | ||||
| WO2009066681A1 |
Other References:
NAKAMURA, Sadako et al.,Daily Feeding of Fructooligosaccharide or Glucomannan Delays Onset of Senescence in SAMP8 Mice,Gastroenterol. Res. Pract.,2014年06月02日,Vol. 2014, Article ID 303184,p. 1-11
Attorney, Agent or Firm:
Naomi Mae
Previous Patent: Polyhydroxyalkanoate and its manufacturing method
Next Patent: Optical microscope system based on ergonomic field of view
Next Patent: Optical microscope system based on ergonomic field of view